{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:39:35Z","timestamp":1792028375131,"version":"4.4.0"},"reference-count":30,"publisher":"Massachusetts Medical Society","issue":"4","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research & Development, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Legend Biotech USA Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,7,27]]},"DOI":"10.1056\/nejmoa2303379","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T11:00:23Z","timestamp":1685962823000},"page":"335-347","source":"Crossref","is-referenced-by-count":831,"title":["Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma"],"prefix":"10.1056","volume":"389","author":[{"given":"Jes\u00fas","family":"San-Miguel","sequence":"first","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4377-9742","authenticated-orcid":false,"given":"Binod","family":"Dhakal","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwee","family":"Yong","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Spencer","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Anguille","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Victoria","family":"Mateos","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fern\u00e1ndez de Larrea","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Touzeau","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Avivi","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cavo","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Ishida","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Roeloffzen","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels W.C.J.","family":"van de Donk","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Dytfeld","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Sidana","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5362-2469","authenticated-orcid":false,"given":"Luciano J.","family":"Costa","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Oriol","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Popat","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Khan","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u00ebl C.","family":"Cohen","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Joy","family":"Ho","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Griffin","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Lendvai","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Lonardi","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Slaughter","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Schecter","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn C.","family":"Jackson","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Connors","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Li","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Zudaire","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Chen","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Gilbert","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-min","family":"Yeh","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nagle","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Florendo","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Pacaud","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Patel","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Harrison","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[{"name":"From the Cancer Center Cl\u00ednica Universidad de Navarra, Centro Investigaci\u00f3n Medica Aplicada, Instituto de Investigaci\u00f3n de Navarra, Centro Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Pamplona (J.S.-M.), the University Hospital of Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro Investigaci\u00f3n del C\u00e1ncer, CIBERONC, Salamanca (M.-V.M.), the Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona (C.F.L.), the Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, Centro Nacional de Investigaciones Oncol\u00f3gicas, CIBERONC, Madrid (J.M.-L.), and the Institut Catal\u00e0 d\u2019Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (A.O.) \u2014 all in Spain; the Medical College of Wisconsin, Milwaukee (B.D.); the University College London Cancer Institute (K.Y.) and University College London Hospitals, NHS Foundat..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000109"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17888"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14213"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(22)00570-5"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000846468.64341.f1"},{"issue":"2","key":"e_1_3_5_7_2","first-page":"e528","article-title":"Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"5","author":"Dimopoulos MA","year":"2021","unstructured":"Dimopoulos MA, Moreau P, Terpos E, et al. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up. HemaSphere 2021;5(2):e528-e528.33554050","journal-title":"HemaSphere"},{"key":"e_1_3_5_8_2","unstructured":"NCCN guidelines: multiple myeloma. Version 3.2023. National Comprehensive Cancer Network 2023."},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010155"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07503-y"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00933-8"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00842"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8009"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-159169"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","unstructured":"Einsele H Cohen AD Delforge M et al. Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel a BCMA-directed CAR-T cell therapy in lenalidomide-refractory patients with progressive multiple myeloma after 1\u20133 prior lines of therapy: CARTITUDE-2 cohort A. Presented at the American Society of Clinical Oncology Annual Meeting Chicago June 3\u20137 2022. abstract.","DOI":"10.1200\/JCO.2022.40.16_suppl.8020"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213614"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-299487"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30152-4"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00128-5"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_3_5_22_2","unstructured":"Common terminology criteria for adverse events (CTCAE) version 5.0. Department of Health and Human Services November 27 2017 (https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf)."},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7157"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/77.4.853"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00579-9"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30734-0"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00592-4"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.04.013"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00629-1"},{"key":"e_1_3_5_30_2","unstructured":"Highlights of prescribing information: ABECMA (idecabtagene vicleucel). Summit NJ: Celgene Corporation a Bristol-Myers Squibb Company 2021 (https:\/\/www.fda.gov\/media\/147055\/download)."},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0141-0"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2303379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:54:10Z","timestamp":1749668050000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2303379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7,27]]}},"alternative-id":["10.1056\/NEJMoa2303379"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2303379","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}